This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Nankai University. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Songdi Wang
Introduction
Songdi Wang is a prominent inventor based in Tianjin, China. He has made significant strides in the field of biomedical engineering, particularly in the development of cardiac organoids. His work focuses on creating advanced models that can mimic the human heart, which is crucial for medical research and therapeutic applications.
Latest Patents
Wang holds a patent for a "Vascularized cardiac organoid with a chamber structure and its preparation method." This innovative patent presents a unique chamber structure within cardiac organoids, which includes a myocardium wall. The cardiac organoids feature a developed vascular network enclosed within the myocardium wall. This network is composed of endothelial cells surrounded by smooth muscle cells, forming branched tubular structures. The presence of vasculature significantly enhances the arrangement of the myocardium, improves the organization of the cardiac cytoskeleton, and promotes the consistency and beating frequency of cardiac cells. Furthermore, the vasculature facilitates the growth and size increase of the cardiac organoids.
Career Highlights
Songdi Wang is affiliated with Nankai University, where he conducts his research and development activities. His contributions to the field of cardiac organoids have positioned him as a leading figure in biomedical innovation. With a focus on enhancing the functionality of cardiac models, Wang's work is paving the way for future advancements in heart disease treatment and regenerative medicine.
Collaborations
Wang collaborates with notable colleagues, including Deling Kong and Zhuangzhuang Yang. Their combined expertise fosters a dynamic research environment that encourages innovation and discovery in the field of cardiac organoid technology.
Conclusion
In summary, Songdi Wang's innovative work in developing vascularized cardiac organoids represents a significant advancement in biomedical engineering. His contributions are essential for the future of heart research and therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
